Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioNumerik Pharmaceuticals Inc.
DescriptionSmall molecule (y-methylene-10-deazaaminopterin) antifolate
Molecular Target Dihydrofolate reductase (DHFR)
Mechanism of ActionDihydrofolate reductase (DHFR) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today